Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1. - Suppr | 超能文献

Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1.

作者信息

Slavin S, Or R, Weiss L, Steiner-Zalz D, Cividalli G, Brautbar C, Weshler Z, Galun E, Samuels S, Galili D

出版信息

Adv Exp Med Biol. 1985;186:813-8. doi: 10.1007/978-1-4613-2463-8_98.

DOI:10.1007/978-1-4613-2463-8_98

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1.

Adv Exp Med Biol. 1985;186:813-8. doi: 10.1007/978-1-4613-2463-8_98.

2

[Prevention of graft versus host disease by in vitro depletion of T lymphocytes with monoclonal antibodies (Campath-1) in patients undergoing bone marrow transplantation].[在接受骨髓移植的患者中，通过单克隆抗体（Campath-1）体外清除T淋巴细胞预防移植物抗宿主病]

Med Clin (Barc). 1988 Oct 22;91(13):488-92.

3

Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.使用Campath-1抗体对供体和受体进行T细胞清除以控制移植物抗宿主病和移植排斥反应。恶性疾病同胞匹配移植的结果。

Bone Marrow Transplant. 1994 May;13(5):597-611.

4

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.用于预防异基因外周血干细胞移植后移植物抗宿主病和移植物排斥反应的CD52抗体。

Bone Marrow Transplant. 2000 Jul;26(1):69-76. doi: 10.1038/sj.bmt.1702477.

5

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.

J Hematother. 1994 Spring;3(1):15-31. doi: 10.1089/scd.1.1994.3.15.

6

Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.小鼠造血干细胞移植后移植物抗白血病效应的流式细胞术分析

Cytometry A. 2015 Apr;87(4):334-45. doi: 10.1002/cyto.a.22619. Epub 2015 Feb 24.

7

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.用于骨髓移植的大鼠单克隆抗体——CAMPATH系列

Adv Exp Med Biol. 1985;186:869-75. doi: 10.1007/978-1-4613-2463-8_105.

8

[Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody].

Schweiz Med Wochenschr. 1985 Oct 26;115(43):1521-2.

9

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.自体移植和同种异体移植中的清除：利用人补体及其他天然效应机制的单克隆抗体。

Prog Clin Biol Res. 1990;333:139-51; discussion 152-4.

10

Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients.供体骨髓中T淋巴细胞的耗竭可防止匹配的异基因白血病骨髓移植受者发生严重的移植物抗宿主病。

Lancet. 1984 Mar 3;1(8375):472-6. doi: 10.1016/s0140-6736(84)92848-4.

引用本文的文献

1

Autoimmune thyroid disease following alemtuzumab therapy and hematopoietic cell transplantation in pediatric patients with sickle cell disease.在患有镰状细胞病的儿科患者中，阿仑单抗治疗和造血细胞移植后发生的自身免疫性甲状腺疾病。

Pediatr Blood Cancer. 2014 Dec;61(12):2307-9. doi: 10.1002/pbc.25102. Epub 2014 Jun 17.

2

Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.裂谷热病毒的反向遗传学技术：治疗方法和疫苗开发的当前及未来应用

Antiviral Res. 2009 Nov;84(2):101-18. doi: 10.1016/j.antiviral.2009.08.002. Epub 2009 Aug 12.